Soleno Therapeutics (SLNO) Change in Account Payables (2016 - 2019)
Historic Change in Account Payables for Soleno Therapeutics (SLNO) over the last 7 years, with Q4 2019 value amounting to $260000.0.
- Soleno Therapeutics' Change in Account Payables rose 17162.53% to $260000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $1.1 million, marking a year-over-year increase of 32610.44%. This contributed to the annual value of $5.7 million for FY2024, which is 31341.11% up from last year.
- Per Soleno Therapeutics' latest filing, its Change in Account Payables stood at $260000.0 for Q4 2019, which was up 17162.53% from -$5000.0 recorded in Q3 2019.
- Soleno Therapeutics' Change in Account Payables' 5-year high stood at $627000.0 during Q1 2016, with a 5-year trough of -$549000.0 in Q2 2016.
- In the last 5 years, Soleno Therapeutics' Change in Account Payables had a median value of $181000.0 in 2015 and averaged $81805.8.
- Per our database at Business Quant, Soleno Therapeutics' Change in Account Payables plummeted by 78536.59% in 2018 and then soared by 89016.39% in 2019.
- Over the past 5 years, Soleno Therapeutics' Change in Account Payables (Quarter) stood at -$330055.0 in 2015, then decreased by 25.08% to -$412828.0 in 2016, then skyrocketed by 90.07% to -$41000.0 in 2017, then tumbled by 785.37% to -$363000.0 in 2018, then surged by 171.63% to $260000.0 in 2019.
- Its last three reported values are $260000.0 in Q4 2019, -$5000.0 for Q3 2019, and $482000.0 during Q2 2019.